vs

Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.

Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $13.8M, roughly 1.4× CB Financial Services, Inc.). On growth, CB Financial Services, Inc. posted the faster year-over-year revenue change (19.9% vs 16.3%). CB Financial Services, Inc. produced more free cash flow last quarter ($17.2M vs $2.4M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs 1.2%).

CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.

Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.

CBFV vs ELMD — Head-to-Head

Bigger by revenue
ELMD
ELMD
1.4× larger
ELMD
$18.9M
$13.8M
CBFV
Growing faster (revenue YoY)
CBFV
CBFV
+3.6% gap
CBFV
19.9%
16.3%
ELMD
More free cash flow
CBFV
CBFV
$14.8M more FCF
CBFV
$17.2M
$2.4M
ELMD
Faster 2-yr revenue CAGR
ELMD
ELMD
Annualised
ELMD
16.7%
1.2%
CBFV

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CBFV
CBFV
ELMD
ELMD
Revenue
$13.8M
$18.9M
Net Profit
$2.8M
Gross Margin
78.4%
Operating Margin
38.1%
19.2%
Net Margin
14.6%
Revenue YoY
19.9%
16.3%
Net Profit YoY
40.3%
EPS (diluted)
$0.90
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBFV
CBFV
ELMD
ELMD
Q4 25
$13.8M
$18.9M
Q3 25
$2.4M
$16.9M
Q2 25
$13.5M
$17.4M
Q1 25
$12.1M
$15.7M
Q4 24
$13.2M
$16.3M
Q3 24
$12.7M
$14.7M
Q2 24
$12.2M
$14.8M
Q1 24
$13.5M
$13.9M
Net Profit
CBFV
CBFV
ELMD
ELMD
Q4 25
$2.8M
Q3 25
$-5.7M
$2.1M
Q2 25
$3.9M
$2.2M
Q1 25
$1.9M
$1.9M
Q4 24
$2.0M
Q3 24
$3.2M
$1.5M
Q2 24
$2.6M
$1.8M
Q1 24
$4.2M
$1.5M
Gross Margin
CBFV
CBFV
ELMD
ELMD
Q4 25
78.4%
Q3 25
78.1%
Q2 25
78.3%
Q1 25
78.0%
Q4 24
77.7%
Q3 24
78.3%
Q2 24
76.2%
Q1 24
74.8%
Operating Margin
CBFV
CBFV
ELMD
ELMD
Q4 25
38.1%
19.2%
Q3 25
-289.8%
15.8%
Q2 25
35.0%
17.5%
Q1 25
19.3%
13.6%
Q4 24
23.1%
15.6%
Q3 24
31.2%
13.2%
Q2 24
26.4%
15.7%
Q1 24
37.9%
13.3%
Net Margin
CBFV
CBFV
ELMD
ELMD
Q4 25
14.6%
Q3 25
-235.2%
12.6%
Q2 25
29.3%
12.7%
Q1 25
15.8%
12.1%
Q4 24
12.1%
Q3 24
25.3%
10.0%
Q2 24
21.8%
12.3%
Q1 24
31.1%
10.8%
EPS (diluted)
CBFV
CBFV
ELMD
ELMD
Q4 25
$0.90
$0.32
Q3 25
$-1.07
$0.25
Q2 25
$0.74
$0.26
Q1 25
$0.35
$0.21
Q4 24
$0.45
$0.22
Q3 24
$0.60
$0.16
Q2 24
$0.51
$0.20
Q1 24
$0.82
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBFV
CBFV
ELMD
ELMD
Cash + ST InvestmentsLiquidity on hand
$31.7M
$13.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$157.5M
$45.4M
Total Assets
$1.5B
$54.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBFV
CBFV
ELMD
ELMD
Q4 25
$31.7M
$13.8M
Q3 25
$55.9M
$14.1M
Q2 25
$64.5M
$15.3M
Q1 25
$61.3M
$15.2M
Q4 24
$49.6M
$16.2M
Q3 24
$147.3M
$13.9M
Q2 24
$142.6M
$16.1M
Q1 24
$73.7M
$11.7M
Stockholders' Equity
CBFV
CBFV
ELMD
ELMD
Q4 25
$157.5M
$45.4M
Q3 25
$152.5M
$44.7M
Q2 25
$148.4M
$43.2M
Q1 25
$148.3M
$43.9M
Q4 24
$147.4M
$43.6M
Q3 24
$149.1M
$41.5M
Q2 24
$142.9M
$44.5M
Q1 24
$141.6M
$42.5M
Total Assets
CBFV
CBFV
ELMD
ELMD
Q4 25
$1.5B
$54.9M
Q3 25
$1.5B
$53.6M
Q2 25
$1.5B
$53.8M
Q1 25
$1.5B
$52.5M
Q4 24
$1.5B
$52.3M
Q3 24
$1.6B
$48.9M
Q2 24
$1.6B
$52.2M
Q1 24
$1.5B
$48.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBFV
CBFV
ELMD
ELMD
Operating Cash FlowLast quarter
$17.8M
$3.0M
Free Cash FlowOCF − Capex
$17.2M
$2.4M
FCF MarginFCF / Revenue
124.1%
12.7%
Capex IntensityCapex / Revenue
4.7%
3.4%
Cash ConversionOCF / Net Profit
1.10×
TTM Free Cash FlowTrailing 4 quarters
$29.5M
$7.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBFV
CBFV
ELMD
ELMD
Q4 25
$17.8M
$3.0M
Q3 25
$4.6M
$169.0K
Q2 25
$4.1M
$3.9M
Q1 25
$4.0M
$2.1M
Q4 24
$6.8M
$3.2M
Q3 24
$3.1M
$2.3M
Q2 24
$-1.2M
$4.5M
Q1 24
$3.3M
$1.4M
Free Cash Flow
CBFV
CBFV
ELMD
ELMD
Q4 25
$17.2M
$2.4M
Q3 25
$4.5M
$-83.0K
Q2 25
$3.9M
$3.7M
Q1 25
$3.9M
$1.9M
Q4 24
$3.4M
$2.9M
Q3 24
$2.2M
$2.3M
Q2 24
$-2.4M
$4.5M
Q1 24
$2.3M
$1.3M
FCF Margin
CBFV
CBFV
ELMD
ELMD
Q4 25
124.1%
12.7%
Q3 25
186.5%
-0.5%
Q2 25
28.8%
21.4%
Q1 25
32.5%
12.2%
Q4 24
26.0%
18.0%
Q3 24
17.4%
15.5%
Q2 24
-19.6%
30.1%
Q1 24
17.0%
9.1%
Capex Intensity
CBFV
CBFV
ELMD
ELMD
Q4 25
4.7%
3.4%
Q3 25
4.3%
1.5%
Q2 25
1.9%
0.8%
Q1 25
0.8%
1.0%
Q4 24
25.1%
1.4%
Q3 24
6.7%
0.3%
Q2 24
10.0%
0.1%
Q1 24
7.2%
0.6%
Cash Conversion
CBFV
CBFV
ELMD
ELMD
Q4 25
1.10×
Q3 25
0.08×
Q2 25
1.05×
1.75×
Q1 25
2.11×
1.10×
Q4 24
1.60×
Q3 24
0.95×
1.57×
Q2 24
-0.44×
2.46×
Q1 24
0.78×
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBFV
CBFV

Segment breakdown not available.

ELMD
ELMD

Homecare$17.3M91%
Other$1.6M9%

Related Comparisons